Simcere Pharma
Nanjing · Founded 1995
About Simcere Pharma
Founded on 28th March 1995, Simcere swiftly evolved from being a pure distributor of pharmaceutical products to become a leading manufacturer and supplier of drugs in China's rapidly growing pharmaceutical market. Simcere currently operates five GMP-certified manufacturing facilities, two nationwide sales and marketing subsidiaries, a research and development center and manages over 4,000 employees. They are the first Chinese chemical and biological drug company to list on the New York Stock Exchange with IPO proceeds reaching US$ 261 million.
Company Facts
- Founded: 1995
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $228.6M
- Funding stage: IPO
- Last round: Post-IPO Equity (Feb 2024)
- Ticker: hkg:2096
- Website: simcere.com
- Phone: +025-85566666
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/simcere-pharma-99498 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.